3
Significance
Over the last decade, structures of broadly neutralizing antibodies have been determined, encompassing all major exposed surfaces on the prefusion-closed HIV-1-envelope (Env) trimer.
To provide insight into how the immune system generated these antibodies along with molecular detail of their recognition, we surveyed known Env-antibody structures. We found that (i) broadly neutralizing antibodies recognized sequence variability and glycan at frequencies similar to their average occurrence on the Env-trimer surface, (ii) almost two-thirds of the paratopes utilized protruding loops, which were otherwise less common; and (iii) the broadest HIV-1-neutralizing antibodies had high levels of SHM, and the most potent unusual recombination, but antibodies with more reproducible B cell ontogenies still neutralized broadly, and these may be better templates for re-elicitation.
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Antibodies against HIV-1 that neutralize a significant fraction of the diverse primary isolates that typify HIV-1 transmission are highly sought. These antibodies target the HIV-1 envelope (Env) trimer, which is comprised of gp120 and gp41 subunits and shielded from immune recognition by extraordinary glycosylation (1), sequence variability (2), and conformational masking (3) . A decade ago, only four such broadly neutralizing antibodies had been identified. However, in 2009, the identification by B cell culture of antibody PG9 (along with a somatic variant PG16) (4) and in 2010 the identification by probe-based sorting of antibody VRC01 (along with somatic variants VRC02 and VRC03) (5) initiated an outbreak of discovery, with dozens of broadly neutralizing antibodies identified by culture or probe-based sorting of B cells from HIV-1 infected donors (reviewed in (6) ).
Importantly, structures for many of these antibodies in complex with HIV-1 Env have been determined, which link antibody function (breadth and potency of neutralization) with molecular features of antibody recognition (paratope) and chemical details of Env-recognized site (epitope). For example, structures of PG9 with scaffolded V1V2 regions of Env (7) and also with Env trimer (8) have revealed a protruding anionic tyrosine-sulfated loop penetrating the glycan shield to interact with a conserved cationic site on V2; similarly structures of VRC01 with core gp120 (9) or with a fully glycosylated Env trimer (10) have revealed how SHM-based optimization of interactions -especially those involving glycan -allows for broad recognition of the CD4-binding site. Most recently, the structure of antibody VRC-PG05 in complex with a glycosylated Env core (11) has shown that even the highly glycosylated center of the Env "silent face" could be recognized by broadly neutralizing antibodies.
The structure of VRC-PG05 in complex with Env completes recognition by structurally characterized antibody of all major exposed surfaces on the prefusion-closed HIV-Env trimer.
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Here we take advantage of this completion to perform a structure-based survey of all antibody-HIV-1 Env structures in the Protein Data Bank (PDB). We limited analyses to structures of human antibodies (with neutralization breadth > 25%) in complex with epitopes on the prefusion-closed Env trimer with resolutions sufficient to define side chain orientation and interactions. The focus on the prefusion-closed conformation of Env alleviated issues of conformational masking and enabled comparisons on a single structural entity. We further classified structures by antibody class (B cell ontogeny and structural mode of recognition) to unique classes and used a bottom-up classification based on residues of each epitope to define epitope categories. We measured antibody neutralization on a diverse cross-clade panel of 208 HIV-1 isolates and correlated structural features of epitope and paratope with functional characteristics of neutralization breadth and potency. We also analyzed paratopes for ease of lineage re-elicitation and epitopes for ease of mimicry. Overall, our structural survey of HIV-1 antibodies targeting the prefusion-closed Env trimer delineates categories, identifies underlying relationships between structural properties of paratope and epitope and functional properties of neutralization, and suggests favorable candidates for vaccine design.
Results

Broadly neutralizing antibodies that recognize the prefusion-closed Env trimer segregate into 20 classes and 6 categories
The PDB contains over 200 coordinate sets for human antibodies in complex with various portions of HIV-1 Env, ranging from fully glycosylated Env trimers to core gp120, scaffolded domains, representative N-linked glycans, and peptide fragments (Dataset S1). We chose to limit our analysis to structures with resolutions sufficient to define chemistry of 6 interaction: for X-ray crystal structures, we used a resolution limit of 3.9 Å, and for cryo-electron microscopy structures, we used a resolution limit of 4.5 Å. Also, we chose to limit our analysis to antibodies that neutralize at least 25% of HIV-1 at 50 μ g/ml, as measured in a cross-clade panel of at least 100 isolates. Finally, to alleviate issues of conformation, we limited our analysis to only those antibodies that recognize the prefusion-closed conformation of Env as this allowed us to focus on a single structural entity: the Env trimer in its prefusion-closed state.
We next used similarity in B cell ontogeny and structural mode of recognition to classify these PDBs into antibody classes (12) ( share the same D3-3 gene and mode of recognition (14, 15) . For antibodies recognizing the spike apex, prior analyses placed antibody lineages PG9, PGT145 and CH01 in the same class (7).
While structural information showed parallel strand recognition for PG9 and CH03 indicating similar classes (16) , structures of PGT145 with Env trimer (17, 18) indicated loop insertion into a trimeric hole at the spike apex, and hence a distinct mode of recognition and class for PGT145.
We used the name of the first identified antibody in each antibody class as the name of the class.
We selected a structural representative antibody for each class based on the most informative structure (for example, choosing an antibody-Env trimer complex over the same antibody with a deglycosylated core gp120) (Fig. 1A ) Based on the 20 representative antibodyantigen complex structures, we defined epitope residues on the prefusion-closed Env trimer by buried surface area calculations (see methods). For 2G12, the most complete antibody-Env 7 complexes defined interactions with only a few N-linked glycans (19) ; therefore, we used published biochemical studies to define the 2G12 epitope residues (20) . Next, we carried out hierarchical clustering of epitope residues, which clustered the 20 antibody epitopes into 6 categories (Fig. 1A,B) . Three of the categories had been previously described: V1V2, glycan-V3
and CD4-binding site, and each of these categories encompassed at least three different antibody classes. Three additional categories were identified, including the "silent face center" (with antibody VRC-PG05), "fusion peptide" (with antibodies PGT151 and VRC34), and "subunit interface" (with antibodies 35O22 and 8ANC195). Beyond shared epitope residues, each of the categories did appear to have specific characteristics. For example, smFRET measurements define three prefusion states (states 1-3) of the Env trimer and found broadly neutralizing antibodies to preferentially recognize state 1 (21); only two antibodies, VRC34.01 (22) and PGT151 (personal communications, Walther Mothes), have thus far been found to shift the smFRET population to state 2, and both were assigned to the same epitope category. Thus, our structural analysis defined six categories of broadly neutralizing antibodies, and antibodies in each category generally shared similar characteristics.
Neutralization characteristics for 20 antibody classes
As the most important functional property of the 20 antibody classes is their ability to neutralize diverse HIV-1 isolates, we felt it important to measure accurately this feature in a way that allowed comparison between different antibodies. We thus measured both neutralization breadth and potency for the representative member of each class on a diverse cross-clade panel of 208 HIV-1 isolates (23) (Fig. 2A,B 2C) . We observed that the average CDR H3 length and heavy chain SHM of the 20 HIV-1 broadly neutralizing antibodies were higher than those of next generation sequencing (NGS) reads from three healthy donors (P<0.0001) (25) .
We also extracted critical features of the paratope (Fig. 2D) . We selected a measure 
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For epitope, we measured several features including sequence conservation, extent of glycan contribution, number of independent sequence elements in each epitope, and the structural variability of the epitope (Fig. 3A-D 
Underlying relationships between neutralization, paratope and epitope
To provide insight into other features specific to these HIV-1 neutralizing antibodies, we correlated neutralization with epitope and paratope features to reveal underlying relationships (Fig. 4A) . Although a number of features correlated with p-values of less than 0.05, when corrected for multiple comparison, few correlations were significant. Significant correlations included the expected positive correlation between surface area of paratope and surface area of epitope (P < 0.0001, r = 0.9845) (Fig. 4B) and a negative correlation between protein and glycan surface areas (P = 0.0002, r = -0.8413) (Fig. 4C) . This negative correlation suggests antibodies to have an overall surface area that can comprise either protein or glycan; thus, a glycan-focused antibody generally has lower protein-interactive surface than a protein-focused antibody, and vice versa.
Other correlations did not achieve statistical significance, but were potentially revealing.
For example, we observed antibody neutralization breadth to correlate positively with degree of heavy chain SHM (P = 0.0510, r = 0.4538) and buried protein-epitope surface area (P = 0.0079, r = 0.5892) and negatively with degree of epitope glycan (P = 0.0105, r = -0.6579) (Fig. 4D) ,
indicating that while antibody recognition can include glycan, this nevertheless reduces breadth.
Meanwhile sequence conservation correlated with size of the epitope (P = 0.0254, r = 0.6961)/paratope (P = 0.0211, r = 0.7110) ( Fig. 4E) , suggesting that one way to overcome variation is by reducing the area of recognized surface. We also noticed that the broadest HIV-1-neutralizing antibodies had high levels of SHM and the most potent had unusual CDR H3s (Fig. 2). Overall, these observations suggested both the frequency and the extent that neutralizing antibodies targeting the prefusion-closed Env trimer utilize protruding loops, unusual recombination, and extensive SHM to overcome immune evasion mechanism of extraordinary glycosylation and high sequence variability.
Re-elicitation: Antibody-lineage based vaccine design
We also analyzed antibodies to identify which B cell ontogenies might be most easily reelicited by antibody-lineage based vaccine design. Such design is premised on the re-elicitation of antibodies with similar ontogenies, through priming of ancestor B cells and induction of their maturation (16, 41, 42) . Two factors affect re-elicitation: the likelihood that an appropriate recombination event produces an appropriate unmutated common ancestor (UCA) and the likelihood that this UCA will mature through processes of SHM to achieve similar functional properties of neutralization. The former is affected by prevalence of appropriate V-genes and by the contribution to the paratope of CDR H3 features such as D-gene and N-nucleotide addition, which we calculated for each of the 20 classes of neutralizing antibodies (Fig. 5) . We also calculated features of SHM, such as the percent of the V gene-contributed paratope surface altered by SHM or the prevalence of rare mutations (43) . Although some of the broadest and most potent antibodies had features that lowered the probability of their re-elicitation, there were antibody classes with less rare SHM and CDR H3 characteristics such as IOMA, as well as antibodies like PG9 with extensive D-gene contributions to antigen recognition that might be reelicited with greater ease.
Discussion
The completion by antibody VRC-PG05 of structural characterization of the recognition by broadly neutralizing antibodies of all major exposed surfaces on the prefusion-closed Env trimer enables both comprehensive and aggregate-level analyses: Relative to paratope, we could address which characteristics allow for broad recognition of the glycosylated and sequencevariable Env trimer, and relative to the Env trimer surface, we could address which features were recognized and which were avoided. For paratope, our results indicated protruding loops and extensive SHM to dominate recognition (an observation previously reported by Klein and colleagues (44) utilizing a less complete set of HIV-1-directed antibodies), although antibodies with more common features could be found. For epitope, our results indicate both glycan and sequence variation to be recognized by antibody, which may relate to the extent that these features dominate the surface of the prefusion-closed Env trimer.
While our focus on the prefusion-closed trimer allowed us to relate properties of recognized epitopes to average properties of the Env trimer in a specific conformation, this focus led to the omission from our analysis of an important class of broadly neutralizing antibodies, those that target the membrane-proximal external region (MPER) ( Fig. S1 and Table S2 ). MPER antibodies generally show low levels of recognition of the native Env trimer (45) and have thus been proposed to recognize Env trimer in a different conformation (46) . In addition to differences in conformation of Env recognized, MPER antibodies also target regions of Env with significantly lower glycan and sequence variability. Thus, the immune-evasion mechanisms that shield the MPER appear to differ from those shielding the prefusion-closed Env trimer, and the antibody mechanisms that allow for recognition of the MPER likely differ as well from those that allow recognition of the closed Env trimer.
In terms of antibody templates most favorable for vaccine design, our analysis suggested the IOMA lineage as being most favorable for re-elicitation by antibody lineage-based approaches due to the lack of unusual features in its B cell ontogeny. Furthermore, in comparison with VRC01 class antibodies, IOMA may overcome the N276-glycan barrier more readily: CDR L1 in IOMA (and in most other antibodies from VL2-23 and related germline genes) has a short α -helix that can accommodate the N276 glycan with fewer mutations than required by VRC01
class antibodies (47) . In terms of features most favorable to epitope-based vaccine design, we note that antibody VRC34.01 had few epitope segments, low epitope-glycan content, and high epitope-conformational variability (48) . These features may suggest that vaccine design based on the epitope of antibody VRC34.01 may be especially promising. Indeed, we recently achieved the elicitation of antibodies in mice, guinea pigs and rhesus macaques that neutralized diverse HIV-1 Env isolates through immunogen design based on the epitope of VRC34.01 (49) . Thus, in addition to revealing features of paratope and epitope that allow for immune recognition of the prefusion closed spike, the structural survey also provides insight into which antibody templates are most suitable for vaccine design.
Materials and Methods
Structural Dataset and Selection of Structural Representative for Each of the 20 Unique
HIV-1 Antibody Classes. All the antibody-antigen complex structures were collected from Protein Data Bank (PDB) (50) using the key words "HIV-1 antibody" on 28 February 2018.
Structures that contain antibody alone were excluded. Non-human and synthetic antibodies were also excluded. The final comprehensive list of current deposited HIV-1 human antibody-antigen complex structures is provided in Dataset S1. Only the antibodies that target envelope trimer neutralize Tier 2 HIV-1 isolates were considered. To focus on broadly neutralizing HIV-1
antibodies, a neutralizing breadth cutoff of >25% was also used. Based on ontogenies in separate donors, we defined 20 unique classes that recognize the prefusion-closed Env trimer (Fig. 1A) .
For each antibody class, we selected the most informative structure based on the following criteria: 1) Resolution cutoff for X-ray crystal structures < 3.9 Å and < 4.5 Å for cryo-EM structures, allowing for a margin of 0.5 Å in resolution if a high resolution antibody-epitope complex were also available.
2) The complex structure of the trimer with highest resolution was selected, followed by glycosylated monomer, by deglycosylated monomer, or by scaffolded domain with highest resolution. The final PDB IDs we selected included 5V8L (18) Epitope and Paratope Buried Surface Area Calculations. The buried surface area between antibody and antigen was calculated using program NACCESS (57) . The epitope residues and paratope residues for each antibody were defined as residues with non-zero buried surface area.
For 2G12, the epitope residues were defined as glycans N295, N332, and N392, based on (20) . Average Glycan Surface Calculations. The glycan surface area of the HIV-1 Env prefusionclosed trimer was calculated applying a two-step procedure. First, we approximated the accessible surface area (ASA), using NACCESS program (57) with the default radius of 1.4 Å, for all protein as well as glycan residues based on a molecular dynamics simulation with a 500-nanosecond timescale (10) . Second, we determined the percentage of the glycan surface area, by dividing the ASA of glycan residues by the sum of the ASAs of protein and glycan residues.
Structural Definition of HIV-1 Env
Number of Epitope Segment Calculations. The number of epitope segment is defined as number of continuous stretches on epitope residues, allowing skipping of one to two residues, which in total have an epitope surface area of greater than the specified threshold (25Å 2 or 100 Å 2 ).
Epitope Structural Variation Calculations. The epitope structural variation for each antibody class was determined by the averaged root-mean-square-deviation of recognized epitope amino acid residues computed pairwise among category members and the unliganded structure (PDB ID: 4ZMJ) (33) using PyMOL software. Antibody 2G12 conformational variability was not calculated due to lack of amino acid epitope residues. (Table S1A -S1C) and HV germline frequency ( Table   S1D ). The next-generation sequencing (NGS) data from healthy donor performed with 5′ primeradapters should avoid bias of germline gene usage. All heavy chain reads shorter than 350 nucleotides were removed, and all lambda and kappa chain reads longer than 300 nucleotides were kept. Germline genes were assigned to all filtered reads using IgBLAST (61) . After assigned all reads, an in-house python script applied to process IgBLAST output, and non-IG sequences were removed. The variation between alleles were ignored, and we treated those alleles as identical VH gene. The VH gene frequency was calculated by the number of reads of VH germline divided by the total good IG sequences.
SHM Rarity. Rarity score of a somatic hypermutation was calculated as 1-frequency of the SHM observed in gene-specific substitution profiles (43) . SHMs with rarity score lower than 0.5% were counted as rare SHMs. (Table S1 ) were assigned to classes (leftmost column, listed by the name of first reported antibody of the class) based on similarities in B cell ontogeny and mode of recognition, with a representative structure and PDB for the class (2nd and 3rd columns from left), which were chosen based on resolution and degree to which Env in the structure resembled prefusion-closed trimer; "*" indicate structures determined in gp120-core context; "#" indicates structures determined with V1/V2 scaffold; "@" indicates glycan N295, N332, and N392 used for 2G12 epitope (see methods). (B) Prefusionclosed Env trimer with molecular surface colored by categories defined in (A). Epitope residues shared by antibodies in separate classes were colored according to surface area and requirements for antibody binding. For example, glycan N276 has interactions with antibody 8ANC195 of the subunit interface category and with multiple antibodies of the CD4-binding site category; however, because glycan N276 is required for 8ANC195, and generally only accommodated by antibodies that target the CD4-binding site, we colored glycan N276 to be part of the subunit interface category. Left image is shown with viral membrane at bottom; right image is rotated 90º to look down on the trimer apex. "*" indicate structures determined in gp120-core context; "#" indicates structures determined with V1/V2 scaffold. Structures denoted with "*" or "#" were included in calculations of the category averages for protruding loop numbers, but not for paratope surface area. P-values were determined using two-tailed Mann-Whitney test. (Table S1 ) were assigned to classes (leftmost column, listed by the name of first reported antibody of the class) based on similarities in B cell ontogeny and mode of recognition, with a representative structure and PDB for the class (2nd and 3rd columns from left), which were chosen based on resolution and degree to which Env in the structure resembled prefusion-closed trimer; "*" indicate structures determined in gp120-core context; "#" indicates structures determined with V1/V2 scaffold; "@" indicates glycan N295, N332, and N392 used for 2G12 epitope (see methods) (B) Prefusion-closed Env trimer with molecular surface colored by categories defined in (A). Epitope residues shared by antibodies in separate classes were colored according to surface area and requirements for antibody binding. For example, glycan N276 has interactions with antibody 8ANC195 of the subunit interface category and with multiple antibodies of the CD4-binding site category; however, because glycan N276 is required for 8ANC195, and generally only accommodated by antibodies that target the CD4-binding site, we colored glycan N276 to be part of the subunit interface category. Left image is shown with viral membrane at bottom; right image is rotated 90º to look down on the trimer apex. K121, T123, P124, V127, M161, T162, R166, D167, K169, I309, Q315, NAG608, T123, V127,  N160, M161, T162, R166, D167, K168, K169, NAG606, NAG607, BMA608, K121, T123, P124,  V127, N160, M161, T162, R166, D167, E275, N276, L277, T278, N279, N280, A281, K282, T283, S365, G366, G367, D368,  I371, M426, G429, G431, Q432, T455, R456, D457, G458, G459, A460, N461, R469, P470, G471,  G472, N474, D477, R480, glycan 276   VRC01  VRC01  5FYJ  X-ray  3.1  Trimer   W 96, K 97, V198, E275, N276, T278, D279, N280, A281, K282, T283, I360, S365, G366, G367,  D368, I371, R425, Q428, R429, V455, R456, D457, G458, C459, K460, S461, T465, E466, T467,  R469, A471, G472, G473, D474, E275, N279, N280, A281, K282, T283, R327, P364, S365, G366, G367, D368, L369,  I371, T372, M373, Y384, K419, I420, K421, I423, T455, G458, G459, R469, P470, G471, G472,  G473, N474, D477, R480, glycan 386   b12  b12  5VN8  Cryo-EM   3.6  Trimer   K178, L179, V181, V182, P183, L184, E185, N185, K185, N185, N187, I188, T189, R192, I194,  N195, N197, T198, S199, T257, N280, A281, H363, S364, S365, G366, G367, D368, P369, E370,  I371, V372, T373, Y384, N386, Q417, C418, R419, K421, N425, M426, W427, Q428, G429,  V430, G431, T455, R456, D457, R460, R469, G471, G472, G473, N474, M475, glycan 197, glycan  362, glycan 386   CH103  CH103  4JAN  X-ray  3.2  gp120   S256, D279, N280, A281, E362, H364, S365, G366, G367, D368, L369, E370, I371, T455, R456,  D457, G458, G459, N460, D461, D462, N463, R469, P470, G471, G472 VRC16.01 VRC16.01 4YDK X-ray 2.1 gp120 Q105, L122, T123, G124, G198, S199, T257, E275, N280, A281, K282, T283, P364, S365, G366,  G367, D368, L369, E370, I371, H375, N425, M426, W427, Q428, G429, G431, Q432, T455, R456,  D457, G458, G459, A460, T463, T467, R469, P470, G471, G472, 
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